Alpha Profiles · Company Profile

Aspire Biopharma Holdings, Inc.

Canonical company identity and public leadership record.

https://registry.alpha.ac/companies/aspire-biopharma-holdings-inc

Entity: Public listing published
Primary listing: NASDAQ: ASBP
Verification: Partially verified
Last reviewed: 2026-09-18T04:48:06.171631+00:00

Overview

Alpha's canonical identity and public leadership record for Aspire Biopharma Holdings, Inc..

Canonical AEGIS identity graph

Executive leadership

Current, confirmed roles are shown only when both the person Profile and supporting source record satisfy the public projection boundary. A missing role is not evidence that it does not exist.

Executive team

2 public records

Ernest J. Scheidemann, Jr.

Chief Financial Officer

State: confirmed
Effective: From Mar 30, 2026
Confidence: 94%
Evidence: ASBP 10-K executive officersMar 30, 2026

Kraig T. Higginson

Chief Executive Officer

State: confirmed
Effective: From Mar 30, 2026
Confidence: 94%
Evidence: ASBP 10-K executive officersMar 30, 2026

Governance leadership

Boards & Committees

Board and committee assignments appear only when the canonical public projection retains a current role and supporting source. Unpublished records are not interpreted as absence.

Record as of Sep 18, 2026. Chair, executive office, Lead Independent Director and committee appointments retain their separate source roles. A complete board composition denominator and committee charters are not established by a partial roster.